Literature DB >> 5219689

Isolation of high-molecular-weight, P32-labeled influenza virus ribonucleic acid.

H O Agrawal, G Bruening.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5219689      PMCID： PMC224235          DOI： 10.1073/pnas.55.4.818

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   12.779


× No keyword cloud information.
  25 in total

1.  Structure of some animal viruses and significance of their components.

Authors:  W SCHAFER
Journal:  Bacteriol Rev       Date:  1963-03

2.  Further studies on the infectivity of ribonucleic acid prepared from influenza-infected cells.

Authors:  H F MAASSAB
Journal:  J Immunol       Date:  1963-02       Impact factor: 5.422

3.  Isolation of ribonucleic acid from purified influenza virus preparation by phenol extraction.

Authors:  F SOKOL; J SZURMAN
Journal:  Acta Virol       Date:  1959-07       Impact factor: 1.162

4.  The ribonucleic acid, lipid, and polysaccharide constituents of influenza virus preparations.

Authors:  L H FROMMHAGEN; C A KNIGHT; N K FREEMAN
Journal:  Virology       Date:  1959-06       Impact factor: 3.616

5.  Failure to recover infective 'ribonucleic acid' from myxovirus preparations.

Authors:  G L ADA; P E LIND; L LARKIN; F M BURNET
Journal:  Nature       Date:  1959-08-01       Impact factor: 49.962

6.  The nucleic acid content of influenza virus.

Authors:  D C BURKE; A ISAACS; J WALKER
Journal:  Biochim Biophys Acta       Date:  1957-12

7.  The nucleic acid and carbohydrate content of influenza virus A and of virus fractions produced by ether disintegration.

Authors:  W FRISCH-NIGGEMEYER; L HOYLE
Journal:  J Hyg (Lond)       Date:  1956-06

8.  The influence of the composition of the medium upon the sedimentation rate of proteins. II. Studies on influenza virus characteristics particles.

Authors:  M A LAUFFER; N W TAYLOR
Journal:  Arch Biochem Biophys       Date:  1953-01       Impact factor: 4.013

9.  The nucleic acid of the Bryan strain of Rous sarcoma virus: purification of the virus and isolation of the nucleic acid.

Authors:  W S Robinson; A Pitkanen; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

10.  Isolation of the nucleic acid of Newcastle disease virus (NDV).

Authors:  P H Duesberg; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205
View more
  12 in total

1.  RNAs of influenza A, B, and C viruses.

Authors:  M B Ritchey; P Palese; E D Kilbourne
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

2.  Purification of Sendai virus.

Authors:  F L Kisseljov; M Mazzarelli; N L Varitch; T I Tikchonenko
Journal:  Arch Gesamte Virusforsch       Date:  1969

3.  Viruses with segmented ribonucleic acid genomes: multiplication of influenza versus reovirus.

Authors:  A J Shatkin
Journal:  Bacteriol Rev       Date:  1971-09

4.  Isolation and partial characterization of nucleic acid of influenza virus.

Authors:  D P Nayak; M A Baluda
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

5.  Preliminary classification of viruses based on quantitative comparisons of viral nucleic acids.

Authors:  A J Bellett
Journal:  J Virol       Date:  1967-04       Impact factor: 5.103

6.  Method for increasing the regularity of isolation of infectious ribonucleic acid from influenza virus.

Authors:  L K Chetverikova; R Y Polyak; L G Yukhnova; A A Smorodintsev
Journal:  J Virol       Date:  1970-08       Impact factor: 5.103

7.  Ribonucleic acid synthesis in cells infected with influenza virus.

Authors:  D P Nayak; M A Baluda
Journal:  J Virol       Date:  1968-02       Impact factor: 5.103

8.  The multiplication of an influenza virus strain in a continuous line of mammalian cells.

Authors:  E M Zitcer; G Bruening; H O Agrawal
Journal:  Arch Gesamte Virusforsch       Date:  1967

9.  Some properties of influenza virus nucleocapsids.

Authors:  D W Kingsbury; R G Webster
Journal:  J Virol       Date:  1969-09       Impact factor: 5.103

10.  Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.

Authors:  Seyed Reza Najafizadeh; Khatereh Amiri; Maryam Moghaddassi; Shaghayegh Khanmohammadi; Hossein Mirmiranpour; Manouchehr Nakhjavani
Journal:  Clin Rheumatol       Date:  2021-05-28       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.